We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$5.5B
AUM Growth
+$123M
Cap. Flow
-$7.48M
Cap. Flow %
-0.14%
Top 10 Hldgs %
35.1%
Holding
1,042
New
82
Increased
192
Reduced
259
Closed
48

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$48.4M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$33.3M
3
NXPI icon
NXP Semiconductors
NXPI
+$27.6M
4
UNH icon
UnitedHealth
UNH
+$26.7M
5
HPQ icon
HP
HPQ
+$18.7M

Sector Composition

Rank Sector Weight
1 Technology 32.45%
2 Financials 12.16%
3 Healthcare 10.83%
4 Consumer Discretionary 9.4%
5 Industrials 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASML icon
26
ASML
ASML
$689B
$71.7M 1.3%
70,154
-1,275
-2% -$1.23M
IBDP
27
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$71.7M 1.3%
2,853,823
+147,369
+5% +$3.69M
MRK icon
28
Merck
MRK
$322B
$69M 1.25%
557,405
+3,056
+0.6% +$394K
IBDQ
29
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$66.7M 1.21%
2,681,190
+173,859
+7% +$4.31M
JPM icon
30
JPMorgan Chase
JPM
$924B
$66M 1.2%
326,083
+79,891
+32% +$15.6M
SPGI icon
31
S&P Global
SPGI
$124B
$63.5M 1.15%
142,353
+3,957
+3% +$1.7M
AMGN icon
32
Amgen
AMGN
$199B
$63.2M 1.15%
202,113
+29,602
+17% +$8.7M
JNJ icon
33
Johnson & Johnson
JNJ
$622B
$58.4M 1.06%
399,574
-325,243
-45% -$48.4M
LPLA icon
34
LPL Financial
LPLA
$25.8B
$57.9M 1.05%
207,475
+12,347
+6% +$3.35M
TJX icon
35
TJX Companies
TJX
$169B
$55.9M 1.02%
508,159
-2,275
-0.4% -$229K
OTIS icon
36
Otis Worldwide
OTIS
$26.6B
$54.6M 0.99%
566,837
+134,333
+31% +$12.9M
DHI icon
37
D.R. Horton
DHI
$39.1B
$47.3M 0.86%
335,406
+8,980
+3% +$1.32M
LOW icon
38
Lowe's Companies
LOW
$112B
$47M 0.85%
213,329
+1,388
+0.7% +$317K
AON icon
39
Aon
AON
$75.3B
$45.8M 0.83%
156,140
+8,478
+6% +$2.51M
SPY icon
40
State Street SPDR S&P 500 ETF Trust
SPY
$776B
$44.1M 0.8%
80,964
-4,417
-5% -$2.31M
ADBE icon
41
Adobe
ADBE
$84.8B
$43.2M 0.78%
77,683
+20,735
+36% +$10M
ABT icon
42
Abbott
ABT
$175B
$42.3M 0.77%
406,724
-10,833
-3% -$1.15M
NXPI icon
43
NXP Semiconductors
NXPI
$69.3B
$39M 0.71%
144,763
-106,991
-42% -$27.6M
GD icon
44
General Dynamics
GD
$102B
$38.9M 0.71%
134,030
-486
-0.4% -$142K
XOM icon
45
ExxonMobil
XOM
$654B
$38.8M 0.7%
336,834
+15,226
+5% +$1.77M
PG icon
46
Procter & Gamble
PG
$340B
$37.7M 0.68%
228,553
-4,736
-2% -$774K
ORCL icon
47
Oracle
ORCL
$346B
$36.6M 0.67%
259,296
-5,798
-2% -$720K
CVX icon
48
Chevron
CVX
$390B
$34.2M 0.62%
218,726
-3,032
-1% -$483K
DHR icon
49
Danaher
DHR
$134B
$34.2M 0.62%
136,806
-2,226
-2% -$562K
IBDR icon
50
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.46B
$33.3M 0.61%
1,398,189
+314,524
+29% +$7.47M

Similar funds

HM Payson & Co's Q2 2024 Portfolio in Review

As of Q2 2024, HM Payson & Co held 1,042 positions worth $5.5B, up 2.3% from $5.38B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

HM Payson & Co's Q2 2024 filing shows 82 new, 192 increased, 259 reduced and 48 closed positions. Its largest new stake was GE Vernova: 5,702 shares worth $978K. The largest sale was Johnson & Johnson, an estimated $48.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.

  • HM Payson & Co's largest Q2 2024 buy was GE Vernova: 5,702 shares worth $978K.
  • HM Payson & Co added most to Amazon in Q2 2024, an estimated $43.6M increase.
  • HM Payson & Co's biggest Q2 2024 reduction was Johnson & Johnson, cutting an estimated $48.4M.
  • HM Payson & Co fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $3.12M.
  • HM Payson & Co's ten largest holdings make up 35% of its $5.5B portfolio in Q2 2024.
  • HM Payson & Co opened 82 new positions and closed 48 in Q2 2024.
  • HM Payson & Co's portfolio value rose 2.3% quarter-over-quarter to $5.5B.

Based on HM Payson & Co's 13F filing for Q2 2024, filed 13 Aug 2024.